Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

OncoVax-P clinical data reported at scientific meeting

Dec. 5, 1997

New tacrine analogue designated for further development

Dec. 5, 1997

Preclinical results reported for JTE-522, a selective COX-2 inhibitor

Dec. 5, 1997

FR-173657 effective in models of kinin-dependent inflammation

Dec. 5, 1997

OR-1384 at least equieffective to 5-ASA in acute and chronic colitis in mice

Dec. 5, 1997

New antipsychotic reported in development at Merck KGaA

Dec. 4, 1997

Profile of an mGluR2/mGluR3 agonist

Dec. 4, 1997

New mechanism involved in the anxiolytic effect of flesinoxan?

Dec. 4, 1997

Abecarnil reverses benzodiazepine resistance in mice

Dec. 4, 1997

Plant extract with both antiinflammatory and antihistaminic activity

Dec. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...